Close
Our goal is to address socioeconomic disadvantage in relation to cardiometabolic health
Our Vision
There are marked ethnic and socioeconomic differences in risks and outcomes of cardiometabolic disease. We will identify opportunities for enhanced population-level prevention across the life course, and for optimised individual treatment to redress inequalities. This will be achieved by capacity building investment in researchers spanning biomedical, social and data sciences, harnessing and enhancing novel data platforms and technology, and partnering with patients and the public in co-creation of aetiological and translational research.
